SkinCure Oncology Submits GentleBeam™ Image-Guided SRT for FDA Clearance
SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation ...
Sensus Healthcare price target lowered to $13 from $18 at Lake Street
Lake Street analyst Ben Haynor lowered the firm’s price target on Sensus Healthcare (SRTS) to $13 from $18 and keeps a Buy rating on the shares ...
The Victoria Advocate13d
SkinCure Oncology Submits GentleBeam™ Image-Guided SRT for FDA Clearance
SkinCure Oncology is the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT), the most advanced nonsurgical treatment ...
Morningstar12d
SkinCure Oncology Submits GentleBeam™ Image-Guided SRT for FDA Clearance
BURR RIDGE, Ill., March 7, 2025 /PRNewswire/ -- SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided ...